Remodulin - NDC Database

8 records found
Page:1
66302-101 May 22, 2002
Remodulin 20 mg/20ml Intravenous; Subcutaneous Injection, Solution by United Therapeutics Corporation
66302-102 May 22, 2002
Remodulin 50 mg/20ml Intravenous; Subcutaneous Injection, Solution by United Therapeutics Corporation
66302-105 May 22, 2002
Remodulin 100 mg/20ml Intravenous; Subcutaneous Injection, Solution by United Therapeutics Corporation
66302-110 May 22, 2002
Remodulin 200 mg/20ml Intravenous; Subcutaneous Injection, Solution by United Therapeutics Corporation
66302-111 Sep 28, 2023
Remodulin 2 mg/20ml Intravenous; Subcutaneous Injection, Solution by United Therapeutics Corporation
66302-112 Sep 28, 2023
Remodulin 4 mg/20ml Intravenous; Subcutaneous Injection, Solution by United Therapeutics Corporation
66302-114 Sep 28, 2023
Remodulin 8 mg/20ml Intravenous; Subcutaneous Injection, Solution by United Therapeutics Corporation
66302-120 Jan 25, 2022
Remodulin 400 mg/20ml Intravenous; Subcutaneous Injection, Solution by United Therapeutics Corporation
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.